Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.

Oxford Ionics founders
  • Oxbotica, a leader in autonomous vehicle software for businesses, has raised US$140 million 
  • Oxford Ionics, whose innovations are taking quantum computing a step closer to reality, has raised £30 million
  • Perspectum, an AI driven medical imaging company, has raised US$36 million

Perspectum, founded in 2012, is a precision health company which develops medical imaging tools to improve the diagnoses of metabolic diseases and cancer. It was born out of a discovery made by Dr Rajarshi Banerjee, now CEO of Perspectum, when researching how to improve the use of MRI in cardiology for his DPhil at the University of Oxford. Read more about the discovery here.

The new $36 million investment was led by Oppenheimer Holdings and completes the first close of its Series C funding round. This brings the total amount raised since inception to around $120 million.

"This new funding will help us to continue innovating new products that will make healthcare safer by providing non-invasive alternatives to biopsy, totally changing how and when we can see and treat many diseases," says Dr Rajarshi Banerjee, founder and CEO of Perspectum. 

Read about the other two spin-outs and the full story on the University of Oxford website. 

Similar stories

Removing bias from healthcare AI tools

Rapid advances in Artificial Intelligence (AI) have opened the way for the creation of a huge range of new healthcare tools, but to ensure that these tools do not exacerbate pre-existing health inequities, researchers urge the use of more representative data in their development.